Share Based Compensation (Tables)

3 Months Ended

Mar. 31, 2019

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

The assumptions used to value SARs granted during 2019 were as follows:

	5-year vesting SARs		7-year vesting SARs
Risk-free interest rate	2.43	%	2.51	%
Expected dividend yield	2.30	%	2.30	%
Expected common stock volatility	35.71	%	40.84	%
Expected life	6.5 years		7.0 years

Schedule of Share-based Compensation, Stock Options, Activity

A summary of activity in our Plans during the first three months of 2019 and 2018 is as follows:

	For the Three Months Ended March 31,
	2019
	Options/SARs	Aggregate Intrinsic Value (in thousands)		Remaining Contractual Term (Yrs.)	Weighted-Average Exercise Price
Outstanding, January 1	232,091				$	17.36
Granted	138,125				23.94
Exercised	—				—
Forfeited	—				—
Expired	—				—
Outstanding, March 31	370,216	$	2,478	7.83	$	19.82
Exercisable, March 31	111,058	$	1,129	6.16	$	16.35

	For the Three Months Ended March 31,
	2018
	Options/SARs		Aggregate Intrinsic Value (in thousands)		Remaining Contractual Term (Yrs.)	Weighted-Average Exercise Price
Outstanding, January 1	250,291					$	17.75
Granted	—					—
Exercised	(200	)				17.79
Forfeited	(3,000	)				26.01
Expired	—					—
Outstanding, March 31	247,091		$	1,918	7.08	$	17.65
Exercisable, March 31	77,581		$	618	5.50	$	17.42